Genprex IPO Lists on the NASDAQ- Gene Therapy Lung Cancer Treatment Gets FundedBlog
offering. Their IPO is now listed and trading on the Nasdaq Exchange under the ticker NASDAQ: GNPX. The offering raised $6.5 million at $5/share with a valuation of $58.5 mill before the offering. Note that Manhattan Street ...